{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:32:00Z","timestamp":1790951520084,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10549-020-05710-6","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T20:10:59Z","timestamp":1591128659000},"page":"465-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1\/BRCA2 breast cancer: a meta-analysis"],"prefix":"10.1007","volume":"182","author":[{"given":"Blanche P.","family":"Alter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4467-1725","authenticated-orcid":false,"given":"Ana F.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"5710_CR1","unstructured":"American Cancer Society (2019\u20132020) Breast Cancer Facts & Figures 2019\u20132020. American Cancer Society, Inc., Atlanta"},{"key":"5710_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cell.2014.12.031","volume":"160","author":"AT Wang","year":"2015","unstructured":"Wang AT, Smogorzewska A (2015) SnapShot: Fanconi anemia and associated proteins. Cell 160:354\u2013354","journal-title":"Cell"},{"key":"5710_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386","volume-title":"Introduction to meta-analysis","author":"M Borenstein","year":"2009","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley, West Sussex"},{"key":"5710_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ng749","volume":"29","author":"JP Ioannidis","year":"2001","unstructured":"Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306\u2013309. https:\/\/doi.org\/10.1038\/ng749","journal-title":"Nat Genet"},{"key":"5710_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/biomet\/asv011","volume":"102","author":"D Zeng","year":"2015","unstructured":"Zeng D, Lin DY (2015) On random-effects meta-analysis. Biometrika 102:281\u2013294. https:\/\/doi.org\/10.1093\/biomet\/asv011","journal-title":"Biometrika"},{"key":"5710_CR6","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372:2243\u20132257. https:\/\/doi.org\/10.1056\/NEJMsr1501341","journal-title":"N Engl J Med"},{"key":"5710_CR7","doi-asserted-by":"publisher","first-page":"4382606","DOI":"10.1155\/2019\/4382606","volume":"2019","author":"DL Ellsworth","year":"2019","unstructured":"Ellsworth DL, Turner CE, Ellsworth RE (2019) A review of the hereditary component of triple negative breast cancer: high- and moderate-penetrance breast cancer genes, low-penetrance loci, and the role of nontraditional genetic elements. J Oncol 2019:4382606. https:\/\/doi.org\/10.1155\/2019\/4382606","journal-title":"J Oncol"},{"key":"5710_CR8","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2018","unstructured":"R Core Team (2018) R: a language and environment for statistical computing. R. Foundation for Statistical Computing, Vienna"},{"key":"5710_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36:1\u201348","journal-title":"J Stat Softw"},{"key":"5710_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2006","unstructured":"Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Easton DF, Stratton MR (2006) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165\u2013167","journal-title":"Nat Genet"},{"key":"5710_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41523-017-0024-8","volume":"3","author":"TP Slavin","year":"2017","unstructured":"Slavin TP, Maxwell KN, Lilyquist J, Vijai J, Neuhausen SL, Hart SN, Ravichandran V, Thomas T, Maria A, Villano D, Schrader KA, Moore R, Hu C, Wubbenhorst B, Wenz BM, D'Andrea K, Robson ME, Peterlongo P, Bonanni B, Ford JM, Garber JE, Domchek SM, Szabo C, Offit K, Nathanson KL, Weitzel JN, Couch FJ (2017) The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ Breast Cancer 3:22. https:\/\/doi.org\/10.1038\/s41523-017-0024-8","journal-title":"NPJ Breast Cancer"},{"key":"5710_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13058-016-0759-4","volume":"18","author":"AD Skol","year":"2016","unstructured":"Skol AD, Sasaki MM, Onel K (2016) The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance. Breast Cancer Res 18:99. https:\/\/doi.org\/10.1186\/s13058-016-0759-4","journal-title":"Breast Cancer Res"},{"key":"5710_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, Lee A, Subramanian D, De LK, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomaki K, Moilanen JS, Turnbull C, Seal S, Mannermaa A, Kallioniemi A, Lindeman GJ, Buys SS, Andrulis IL, Radice P, Tondini C, Manoukian S, Toland AE, Miron P, Weitzel JN, Domchek SM, Poppe B, Claes KB, Yannoukakos D, Concannon P, Bernstein JL, James PA, Easton DF, Goldgar DE, Hopper JL, Rahman N, Peterlongo P, Nevanlinna H, King MC, Couch FJ, Southey MC, Winqvist R, Foulkes WD, Tischkowitz M (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497\u2013506","journal-title":"N Engl J Med"},{"key":"5710_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13058-018-0935-9","volume":"20","author":"N Weber-Lassalle","year":"2018","unstructured":"Weber-Lassalle N, Hauke J, Ramser J, Richters L, Gross E, Blumcke B, Gehrig A, Kahlert AK, Muller CR, Hackmann K, Honisch E, Weber-Lassalle K, Niederacher D, Borde J, Thiele H, Ernst C, Altmuller J, Neidhardt G, Nurnberg P, Klaschik K, Schroeder C, Platzer K, Volk AE, Wang-Gohrke S, Just W, Auber B, Kubisch C, Schmidt G, Horvath J, Wappenschmidt B, Engel C, Arnold N, Dworniczak B, Rhiem K, Meindl A, Schmutzler RK, Hahnen E (2018) BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer. Breast Cancer Res 20:7. https:\/\/doi.org\/10.1186\/s13058-018-0935-9","journal-title":"Breast Cancer Res"},{"key":"5710_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1200\/JCO.19.01907","volume":"38","author":"X Yang","year":"2020","unstructured":"Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, Adank MA, Adlard J, Aittomaki K, Andrulis IL, Ang P, Barwell J, Bernstein JL, Bobolis K, Borg A, Blomqvist C, Claes KBM, Concannon P, Cuggia A, Culver JO, Damiola F, de Pauw A, Diez O, Dolinsky JS, Domchek SM, Engel C, Evans DG, Fostira F, Garber J, Golmard L, Goode EL, Gruber SB, Hahnen E, Hake C, Heikkinen T, Hurley JE, Janavicius R, Kleibl Z, Kleiblova P, Konstantopoulou I, Kvist A, Laduca H, Lee ASG, Lesueur F, Maher ER, Mannermaa A, Manoukian S, McFarland R, McKinnon W, Meindl A, Metcalfe K, Mohd Taib NA, Moilanen J, Nathanson KL, Neuhausen S, Ng PS, Nguyen-Dumont T, Nielsen SM, Obermair F, Offit K, Olopade OI, Ottini L, Penkert J, Pylkas K, Radice P, Ramus SJ, Rudaitis V, Side L, Silva-Smith R, Silvestri V, Skytte AB, Slavin T, Soukupova J, Tondini C, Trainer AH, Unzeitig G, Usha L, van Overeem HT, Whitworth J, Wood M, Yip CH, Yoon SY, Yussuf A, Zogopoulos G, Goldgar D, Hopper JL, Chenevix-Trench G, Pharoah P, George SHL, Balmana J, Houdayer C et al (2020) Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol 38:674\u2013685. https:\/\/doi.org\/10.1200\/JCO.19.01907","journal-title":"J Clin Oncol"},{"key":"5710_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmg.2006.043257","volume":"44","author":"BP Alter","year":"2007","unstructured":"Alter BP, Rosenberg PS, Brody LC (2007) Clinical and molecular features associated with biallelic mutations in FANCD1\/BRCA2. J Med Genet 44:1\u20139","journal-title":"J Med Genet"},{"key":"5710_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/1468-2389.00156","volume":"8","author":"JE Hunter","year":"2000","unstructured":"Hunter JE, Schmidt FL (2000) Fixed effects vs random effects meta-analysis. Int J Select Assess 8:275\u2013292","journal-title":"Int J Select Assess"},{"key":"5710_CR18","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, Moore R, Thomas A, Lilyquist J, Feng B, McFarland R, Pesaran T, Huether R, LaDuca H, Chao EC, Goldgar DE, Dolinsky JS (2017) Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol 3:1190\u20131196. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0424","journal-title":"JAMA Oncol"},{"key":"5710_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2956","author":"HM Lu","year":"2018","unstructured":"Lu HM, Li S, Black MH, Lee S, Hoiness R, Wu S, Mu W, Huether R, Chen J, Sridhar S, Tian Y, McFarland R, Dolinsky J, Tippin Davis B, Mexal S, Dunlop C, Elliott A (2018) Association of breast and ovarian cancers with predisposition genes identified by large-scale sequencing. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2956","journal-title":"JAMA Oncol"},{"key":"5710_CR20","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, Katagiri T, Yoshida T, Nakamura S, Sugano K, Miki Y, Hirata M, Matsuda K, Spurdle AB, Kubo M (2018) Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun 9:4083. https:\/\/doi.org\/10.1038\/s41467-018-06581-8","journal-title":"Nat Commun"},{"key":"5710_CR21","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djy106","volume":"110","author":"H Shimelis","year":"2018","unstructured":"Shimelis H, LaDuca H, Hu C, Hart SN, Na J, Thomas A, Akinhanmi M, Moore RM, Brauch H, Cox A, Eccles DM, Ewart-Toland A, Fasching PA, Fostira F, Garber J, Godwin AK, Konstantopoulou I, Nevanlinna H, Sharma P, Yannoukakos D, Yao S, Feng BJ, Tippin Davis B, Lilyquist J, Pesaran T, Goldgar DE, Polley EC, Dolinsky JS, Couch FJ (2018) Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing. J Natl Cancer Inst 110:855\u2013862. https:\/\/doi.org\/10.1093\/jnci\/djy106","journal-title":"J Natl Cancer Inst"},{"key":"5710_CR22","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/ijc.32184","volume":"145","author":"M Deng","year":"2019","unstructured":"Deng M, Chen HH, Zhu X, Luo M, Zhang K, Xu CJ, Hu KM, Cheng P, Zhou JJ, Zheng S, Chen YD (2019) Prevalence and clinical outcomes of germline mutations in BRCA1\/2 and PALB2 genes in 2769 unselected breast cancer patients in China. Int J Cancer 145:1517\u20131528. https:\/\/doi.org\/10.1002\/ijc.32184","journal-title":"Int J Cancer"},{"key":"5710_CR23","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/jco.18.01854","volume":"37","author":"AW Kurian","year":"2019","unstructured":"Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A, Miller D, Penberthy LS, Katz SJ (2019) Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol 37:1305\u20131315. https:\/\/doi.org\/10.1200\/jco.18.01854","journal-title":"J Clin Oncol"},{"key":"5710_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ajmg.a.32080","volume":"146A","author":"TA Briggs","year":"2008","unstructured":"Briggs TA, Abdel-Salam GM, Balicki M, Baxter P, Bertini E, Bishop N, Browne BH, Chitayat D, Chong WK, Eid MM, Halliday W, Hughes I, Klusmann-Koy A, Kurian M, Nischal KK, Rice GI, Stephenson JB, Surtees R, Talbot JF, Tehrani NN, Tolmie JL, Toomes C, van der Knaap MS, Crow YJ (2008) Cerebroretinal microangiopathy with calcifications and cysts (CRMCC). Am J Med Genet A 146A:182\u2013190","journal-title":"Am J Med Genet A"},{"key":"5710_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s10038-019-0612-6","volume":"64","author":"A Vagena","year":"2019","unstructured":"Vagena A, Papamentzelopoulou M, Kalfakakou D, Kollia P, Papadimitriou C, Psyrri A, Apostolou P, Fountzilas G, Konstantopoulou I, Yannoukakos D, Fostira F (2019) PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk. J Hum Genet 64:767\u2013773. https:\/\/doi.org\/10.1038\/s10038-019-0612-6","journal-title":"J Hum Genet"},{"key":"5710_CR26","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/cncr.32083","volume":"125","author":"JN Weitzel","year":"2019","unstructured":"Weitzel JN, Neuhausen SL, Adamson A, Tao S, Ricker C, Maoz A, Rosenblatt M, Nehoray B, Sand S, Steele L, Unzeitig G, Feldman N, Blanco AM, Hu D, Huntsman S, Castillo D, Haiman C, Slavin T, Ziv E (2019) Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Cancer 125:2829\u20132836. https:\/\/doi.org\/10.1002\/cncr.32083","journal-title":"Cancer"}],"updated-by":[{"DOI":"10.1007\/s10549-020-05775-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000}}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05710-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:40:46Z","timestamp":1622594446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05710-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5710"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05710-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10549-020-05775-3","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"30 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of the article, the first sentence in the abstract was published incorrectly.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"BPA declares that she has no conflict of interest. AFB declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}